Wird geladen...
Clinical Outcomes with Use of Erythropoiesis Stimulating Agents in Patients with the HeartMate II Left Ventricular Assist Device
OBJECTIVES: We evaluated clinical outcomes associated with ESA use in LVAD-supported patients. BACKGROUND: Use of erythropoiesis stimulating agents (ESAs) in patients with left ventricular assist devices (LVADs) may minimize blood transfusions and decrease allosensitization. ESAs increase thrombotic...
Gespeichert in:
| Veröffentlicht in: | JACC Heart Fail |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4766587/ https://ncbi.nlm.nih.gov/pubmed/25660839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jchf.2014.08.005 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|